Janssen-Cilag AS is a pharmaceutical company that is part of the Johnson & Johnson group. The company focuses on the development, production and marketing of medicines in various therapeutic areas, including oncology, immunology, neurology and infectious diseases. Janssen-Cilag aims to improve patients' quality of life through innovative treatment methods and medicines.
The company is known for its commitment to research and development, and invests significant resources in clinical studies to find new and effective treatments. Janssen-Cilag also collaborates with healthcare and academic institutions to promote scientific knowledge and development within the pharmaceutical industry. Through its work, the company contributes to meeting health challenges both nationally and internationally.
